Clinical Trials in Atlanta

Showing 12261-12280 of 19,805 trials

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

NCT01146834

This phase III randomized trial compares three different peripheral stem cell mobilization regimens for patients with multiple myeloma who have received primary induction therapy or other therapies. Up to 180 patients will be enrolled. Patients eligible for treatment will be randomized to one of the three following mobilization regimens: Arm A = VELCADE, CYCLOPHOSPHAMIDE, \& G-CSF Arm B = VELCADE \& G-CSF Arm C = CYCLOPHOSPHAMIDE \& G-CSF Arm D = PLERIXAFOR \& G-CSF Arm E = PLERIXAFOR, VELCADE, \& G-CSF

Multiple Myeloma

Weill Medical College of Cornell University47 participantsStarted Mar 2011

Atlanta, Georgia, United States • New York, New York, United States • New York, New York, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder

NCT01878292

The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in adolescent outpatients (12-17) with major depressive disorder.

Major Depressive Disorder

Forest Laboratories529 participantsStarted Jul 2013

Imperial, California, United States • Los Angeles, California, United States • Murrieta, California, United States +49 more locations

Trial of Three Stem Cell Mobilization Regimens for Multiple Myeloma

Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder

Find Trials by Condition in Atlanta

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Pediatric Open-Label Extension Study

12-Week Study of Plecanatide for CIC (The CIC3 Study)

Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

EverFlex Post Approval Study

Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome

Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma

Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients

Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease

Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment

An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer